跳至主要内容
临床试验/CTRI/2023/08/057101
CTRI/2023/08/057101尚未招募2/3 期

A Pharmaco Clinical Comparative Study Of Jatamansi (Nardostachys jatamansi DC.) and Ashwagandha (Withania somnifera Dunal) Moola Churna In The Management Of Anidra (Insomnia )

Government Ayurvedic College1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年12月9日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Subjective Parameter: Grading will be done with sign & symptoms of Anidra Hb TLC DLC SGOT/PT Serum Creatinine

研究概览

简要总结

In this trial we are selecting patients of Anidra in two groups, in which we will do intervention study of drug Ashawagandha mool choorana and jatamansi mool choorana in the form of capsule with the dose of 2 gm  OD at  night with luke warm water . Assessment will be done on the subjective parameters for anidra disease.

Route of administration: Oral

Follow up : Day 15, Day 30, Day 37

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with written consent.
  • Patients having clinical features of Anidra as Angamarda, Shirogaurava, Jrambhika, Bhrama, Tandra, Jadyata.3) Patients with computer, mobile screening time less than 6 hours.

排除标准

  • Patients below the age of 18 Years and above the age of 60 years.
  • pregnant and lactating mothers.
  • Patients with history of any serious systemic illness hyper/hypo tension.
  • patients taking medications like antidepressants, sleeping pills 5) Patients with computer, mobile screening time more than 6 hours.

结局指标

主要结局

Subjective Parameter: Grading will be done with sign & symptoms of Anidra Hb TLC DLC SGOT/PT Serum Creatinine

时间窗: At start of the trial and after 1 month of intervention of Ashwagandha powder & jatamansi powder, last follow up after 7 days of stopping medicine

次要结局

  • Subjective Parameter Grading will be done with sign & symptoms of Anidra Hb TLC DLC(At start of the trial & after 1 month of intervention of Ashwagandha powder & jatamansi powder, last followup after 7 days of stopping the medicine.)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验